Venus Remedies Ltd

CIN Change and MOA alteration

• CIN changed from L24232CH1989PLC009705 to L21002CH1989PLC009705.
• Change resulted from alteration of object clause and amended MOA approved by Special Resolution on 20 August 2026.
• Certificate of Registration of the Special Resolution confirming alteration and updated CIN issued by MCA.
• Exchanges are requested to update the CIN in the Corporate Information section.

Venus Remedies Ltd: Closure of Trading Window from October 1, 2026 till 48 hours after declaration of unaudited financial results for the period ending September 30, 2026

Special window for re-lodgement of physical share transfers

• Announcement about a special window for re-lodgement of physical share transfer requests.
• Related SEBI notices dated July 2, 2025 and January 30, 2026 referenced.
• No financial impact or governance changes disclosed in this update.

AGM Details

• Date, time, mode: 20 August 2026 at 11:30 AM via VC/OAVM.
• Record date: 13 August 2026.

Key Resolutions

• Ordinary: Receive, consider and adopt standalone financial statements for year ended 31 March 2026.
• Ordinary: Final dividend of Rs 10 per equity share.
• Ordinary: Re-appoint Ashutosh Jain as director by rotation.
• Ordinary: Re-appoint Peeyush Jain as director by rotation.
• Ordinary: Re-appoint Manu Chaudhary as Joint Managing Director for five years.
• Ordinary: Re-appoint Saransh Chaudhary as director for five years.
• Ordinary: Appoint Dr. Gurminder Singh as Non-Executive Independent Director for five years.
• Ordinary: Appoint Dr. Savita Gupta as Non-Executive Independent Director for five years.
• Special: Alter Memorandum of Association.
• Special: Adopt new Articles of Association.

Voting Results

• All resolutions passed with requisite majority.
• No resolution failed; no significant dissent noted.

Dividend

• Final dividend of Rs 10 per equity share approved.

Director Changes

• Re-appoint Ashutosh Jain as director by rotation.
• Re-appoint Peeyush Jain as director by rotation.
• Re-appoint Manu Chaudhary as Joint Managing Director for five years.
• Appoint Saransh Chaudhary as Director for five years.
• Appoint Dr. Gurminder Singh as Non-Executive Independent Director for five years.
• Appoint Dr. Savita Gupta as Non-Executive Independent Director for five years.

Auditors

• Remuneration of cost auditor for financial year 2026-27 ratified.

Material Related Party Transactions

• No material related party transactions disclosed in AGM.

Other Material Approvals

• Special resolutions to alter Memorandum and Articles of Association approved.

Venus Remedies Limited AGM filing chunk contains no extractable details

Venus Remedies Ltd AGM filing excerpt contains no extractable AGM details

Executive Director appointment

• Appointed Saransh Chaudhary as Executive Director (Whole-time) for 5 years from 26 May 2026.
• Profile: heads R&D and operations; M.Sc., M.Phil, Ph.D.; 30+ years in pharma.
• Related to multiple directors on the board.

Non-Executive Independent Director appointment

• Appointed Dr. Gurminder Singh Bedi as Non-Executive Independent Director for 5 years from 26 May 2026.
• Not related to any board member.
• Profile: B.Tech, M.E., PhD; 35+ years; Professor at UIET, Panjab University.

Joint Managing Director re-appointment

• Re-appointed Dr. Manu Chaudhary as Joint Managing Director for five years from 1 October 2026.
• Profile: Head of R&D and operations; Genetics Ph.D.; 30+ years in pharma; led Baddi facility.
• Not related to any board member.

Non-Executive Independent Director re-appointment

• Re-appointed Dr. Savita Gupta as Non-Executive Independent Director for second five-year term from 29 December 2026.
• Profile: Orthopaedic surgeon; 33 years post-MS; Gold Medalist.
• Not related to any board member.